BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ben Abdallah H, Fogh K, Bech R. Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review. Int Wound J 2019;16:511-21. [PMID: 30604927 DOI: 10.1111/iwj.13067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ben Abdallah H, Fogh K, Bech R. Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review. Int Wound J 2019;16:511-21. [PMID: 30604927 DOI: 10.1111/iwj.13067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Marasca C, Fontanella G, Annunziata MC, Marasca D, Fabbrocini G. Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case. Int Wound J 2019;16:1047-8. [PMID: 30938050 DOI: 10.1111/iwj.13123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Isami Y, Kawase Y, Kondo A, Akita W, Yasuda K, Matsutani T, Mitsui H. Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis. J Dermatol 2020;47:e213-5. [PMID: 32162361 DOI: 10.1111/1346-8138.15303] [Reference Citation Analysis]
4 Wu N, Zhang B, Wang T, Shen M, Zeng X. Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review. Front Immunol 2021;12:667430. [PMID: 34093563 DOI: 10.3389/fimmu.2021.667430] [Reference Citation Analysis]
5 Morgenstjerne-Schwenck LET, Knudsen JT, Prasad SC. Efficacy and safety of skin grafting in treatment of vasculitic ulcer and pyoderma gangrenosum-A systematic review. Wound Repair Regen 2021;29:240-53. [PMID: 33377584 DOI: 10.1111/wrr.12882] [Reference Citation Analysis]